Research map: β2-microglobulin, not muscle mass, accounts for the association between eGFR discordance and mortality in CKD

Back to the article

Papers in this map

  1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · Paul E. Stevens · 2024 · 8239 citations · Cited by this paper
  2. The CDKN2A/B rs10811661 polymorphism is associated with metabolic syndrome, insulin resistance, and lipid levels in individuals with obesity and impaired fasting glucose · 2026 · Related
  3. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race · Lesley A. Inker · 2021 · 4530 citations · Cited by this paper
  4. Resolving method-dependent M-protein detection: a case of oligoclonality revealed through complementary immunotyping techniques · 2026 · Related
  5. Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C · Lesley A. Inker · 2012 · 4136 citations · Cited by this paper
  6. Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort · 2026 · Related
  7. Factors other than glomerular filtration rate affect serum cystatin C levels · Lesley A. Stevens · 2009 · 807 citations · Cited by this paper
  8. Inter-laboratory variability in vancomycin measurement in an external quality assessment scheme 2016–2025 · 2026 · Related
  9. Health Behaviours, Socioeconomic Status, and Mortality: Further Analyses of the British Whitehall II and the French GAZEL Prospective Cohorts · Silvia Stringhini · 2011 · 359 citations · Cited by this paper
  10. Modest sensitivity of 24 h urine free cortisol LC-MS/MS to detect Cushing's disease · 2026 · Related
  11. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: ‘Shrunken pore syndrome’ · ANDERS O. GRUBB · 2015 · 140 citations · Cited by this paper
  12. Elevated IL-27 and altered anti-inflammatory cytokine levels in SLE patients with end-stage renal disease · 2026 · Related
  13. The Difference Between Cystatin C– and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) · Onur Potok · 2020 · 134 citations · Cited by this paper
  14. Evaluating prognostic performance for acute delta changes of high-sensitivity cardiac troponin T in emergency department patients · 2026 · Related
  15. Discordances Between Creatinine- and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice · Juan Jesús Carrero · 2023 · 111 citations · Cited by this paper
  16. Establishment of PCOS-specific prolactin reference intervals to optimize laboratory demand management for macroprolactin screening · 2026 · Related
  17. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD · Xun Liu · 2016 · 100 citations · Cited by this paper
  18. From analytical metrics to clinical impact: Rethinking sigma metrics in the era of EFLM-based specifications · 2026 · Related
  19. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality · Debbie C. Chen · 2022 · 94 citations · Cited by this paper
  20. Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins · Markus Sällman Almén · 2018 · 88 citations · Cited by this paper
  21. Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options · ANDERS O. GRUBB · 2020 · 84 citations · Cited by this paper
  22. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease · Christian Bjurman · 2015 · 81 citations · Cited by this paper
  23. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors · Mette-Triin Purde · 2015 · 73 citations · Cited by this paper
  24. Socioeconomic inequalities in health after age 50: Are health risk behaviors to blame? · Benjamín A. Shaw · 2013 · 72 citations · Cited by this paper
  25. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure · Debbie C. Chen · 2022 · 69 citations · Cited by this paper
  26. Discrepancies between Cystatin C–Based and Creatinine-Based eGFR · Danielle K. Farrington · 2023 · 64 citations · Cited by this paper
  27. Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR · Yeli Wang · 2023 · 60 citations · Cited by this paper
  28. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome · Qianrong Zheng · 2025 · 59 citations · Cited by this paper
  29. The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio · Erik Herou · 2019 · 53 citations · Cited by this paper
  30. Ratio of cystatin C and creatinine-based estimates of the glomerular filtration rate predicts mortality in healthy seniors independent of kidney function · Mette-Triin Purde · 2016 · 40 citations · Cited by this paper
  31. Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients · Liana Xhakollari · 2021 · 36 citations · Cited by this paper
  32. Selective glomerular hypofiltration syndrome · Borja Quiroga · 2023 · 25 citations · Cited by this paper
  33. Difference Between Estimated GFR Based on Cystatin C Versus Creatinine and Incident Atrial Fibrillation: A Cohort Study of the UK Biobank · Ga Young Heo · 2024 · 24 citations · Cited by this paper
  34. Difference between kidney function by cystatin C versus creatinine and association with muscle mass and frailty · Julia H. Yuan · 2024 · 23 citations · Cited by this paper
  35. Discordance in Creatinine- and Cystatin C–Based eGFR and Clinical Outcomes · Michelle M. Estrella · 2025 · 22 citations · Cited by this paper
  36. Complex Etiologies of the Discordance Between Cystatin C– and Creatinine-Based Estimated GFR and Its Adverse Associations: Findings From the CRIC Study · Ian Ellis McCoy · 2025 · 18 citations · Cited by this paper
  37. Cystatin C and Creatinine Concentrations Are Uninformative Biomarkers of Sarcopenia: A Cross-Sectional NHANES Study · Lokesh N. Shah · 2023 · 16 citations · Cited by this paper
  38. Discordance between cystatin C–based and creatinine-based estimated glomerular filtration rate and health outcomes in adults: a systematic review and meta-analysis · Qiaoling Liu · 2025 · 13 citations · Cited by this paper
  39. Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome – a new kidney disorder defining selective glomerular hypofiltration syndromes – calls for expansion of the international KDIGO guidelines · Anna Åkesson · 2025 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)